Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

102 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Thymidylate synthase and folyl-polyglutamate synthase are not clinically useful markers of response to pemetrexed in patients with malignant pleural mesothelioma.
Lustgarten DE, Deshpande C, Aggarwal C, Wang LC, Saloura V, Vachani A, Wang LP, Litzky L, Feldman M, Creaney J, Nowak AK, Langer C, Inghilleri S, Stella G, Albelda SM. Lustgarten DE, et al. Among authors: litzky l. J Thorac Oncol. 2013 Apr;8(4):469-77. doi: 10.1097/JTO.0b013e318283da3e. J Thorac Oncol. 2013. PMID: 23486267 Free PMC article.
Adenovirus-mediated herpes simplex virus thymidine kinase/ganciclovir gene therapy in patients with localized malignancy: results of a phase I clinical trial in malignant mesothelioma.
Sterman DH, Treat J, Litzky LA, Amin KM, Coonrod L, Molnar-Kimber K, Recio A, Knox L, Wilson JM, Albelda SM, Kaiser LR. Sterman DH, et al. Among authors: litzky la. Hum Gene Ther. 1998 May 1;9(7):1083-92. doi: 10.1089/hum.1998.9.7-1083. Hum Gene Ther. 1998. PMID: 9607419 Clinical Trial.
A pilot study of systemic corticosteroid administration in conjunction with intrapleural adenoviral vector administration in patients with malignant pleural mesothelioma.
Sterman DH, Molnar-Kimber K, Iyengar T, Chang M, Lanuti M, Amin KM, Pierce BK, Kang E, Treat J, Recio A, Litzky L, Wilson JM, Kaiser LR, Albelda SM. Sterman DH, et al. Among authors: litzky l. Cancer Gene Ther. 2000 Dec;7(12):1511-8. doi: 10.1038/sj.cgt.7700269. Cancer Gene Ther. 2000. PMID: 11228529 Clinical Trial.
Gene expression profiling of malignant mesothelioma.
Singhal S, Wiewrodt R, Malden LD, Amin KM, Matzie K, Friedberg J, Kucharczuk JC, Litzky LA, Johnson SW, Kaiser LR, Albelda SM. Singhal S, et al. Clin Cancer Res. 2003 Aug 1;9(8):3080-97. Clin Cancer Res. 2003. PMID: 12912960
Long-term follow-up of patients with malignant pleural mesothelioma receiving high-dose adenovirus herpes simplex thymidine kinase/ganciclovir suicide gene therapy.
Sterman DH, Recio A, Vachani A, Sun J, Cheung L, DeLong P, Amin KM, Litzky LA, Wilson JM, Kaiser LR, Albelda SM. Sterman DH, et al. Among authors: litzky la. Clin Cancer Res. 2005 Oct 15;11(20):7444-53. doi: 10.1158/1078-0432.CCR-05-0405. Clin Cancer Res. 2005. PMID: 16243818 Clinical Trial.
A 10-gene classifier for distinguishing head and neck squamous cell carcinoma and lung squamous cell carcinoma.
Vachani A, Nebozhyn M, Singhal S, Alila L, Wakeam E, Muschel R, Powell CA, Gaffney P, Singh B, Brose MS, Litzky LA, Kucharczuk J, Kaiser LR, Marron JS, Showe MK, Albelda SM, Showe LC. Vachani A, et al. Among authors: litzky la. Clin Cancer Res. 2007 May 15;13(10):2905-15. doi: 10.1158/1078-0432.CCR-06-1670. Clin Cancer Res. 2007. PMID: 17504990
102 results